Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | COL16A1 |
| Upstream (Parents) |
|---|
| (<<) COL11A1 → COL16A1 |
| (<<) COMP → COL16A1 |
| (<<) OLFML2B → COL16A1 |
| (<<) MXRA8 → COL16A1 |
| Downstream (Children) |
|---|
| COL16A1 → GAP43 (>>) |
| COL16A1 → NPTXR (>>) |
| COL16A1 → KCNJ12 (>>) |
| COL16A1 → DLX5 (>>) |
| COL16A1 → LSAMP (>>) |
| COL16A1 → ZNF287 (>>) |
| COL16A1 → PPEF1 (>>) |
| COL16A1 → UPK1A (>>) |
| COL16A1 → SV2B (>>) |
| COL16A1 → MAGEL2 (>>) |
| COL16A1 → CRTAC1 (>>) |
| COL16A1 → PDZRN4 (>>) |
| COL16A1 → NUDT11 (>>) |
| COL16A1 → UNC5C (>>) |
| COL16A1 → UBA6 (>>) |
| COL16A1 → HNF1A (>>) |
| COL16A1 → ONECUT2 (>>) |
| COL16A1 → HIST1H2BH (>>) |
| COL16A1 → SLCO3A1 (>>) |
| COL16A1 → FMOD (>>) |
